Inflammatory thoughts about glioma gene therapy

Nature Medicine

Volumn 5, Issue 11, 1999, Pages 1237-1238

  Kielian, Tammy ^a   Hickey, William F ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GANCICLOVIR; THYMIDINE KINASE;

ADENOVIRUS; ASTROCYTE; CHRONIC INFLAMMATION; DEMYELINATION; GENE THERAPY; GENETIC TRANSDUCTION; GLIOMA; HERPES SIMPLEX VIRUS; MACROPHAGE; MICROGLIA; PRIORITY JOURNAL; SHORT SURVEY; SUICIDE GENE; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL; TUMOR CELL DESTRUCTION;

ADENOVIRIDAE; BRAIN NEOPLASMS; ENCEPHALITIS; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; GLIOMA; HERPESVIRUS 1, HUMAN; HUMANS; THYMIDINE KINASE;

EID: 0032724305     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/15188     Document Type: Short Survey

References (7)

1. Freeman, S.M., Ramesh, R. & Marrogi, A.J. Immune system in suicide-gene therapy. Lancet 349, 2-3 (1997).
2. Dewey, H.A. et al. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials. Nature Med. 5, 1256-1263 (1999).
3. Kruse, C.A. et al. A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: A comparison to 9L gliosarcoma. J. Neuro-Oncol. 22, 191-200 (1994).
4. Yang, Y. et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl. Acad. Sci. USA 91, 4407-4411 (1994).
5. Worgall, S. et al. Selective expansion of alveolar macrophages in vivo by adenovirus-mediated transfer of the murine granulocyte-macrophage colony-stimulating factor cDNA. Blood 93, 655-666 (1999).
6. McRae, B.L., Vanderlugt, C.L., Dal Canto, M.C., St Miller, S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182, 75-85 (1995).
7. Miller, S.D. et al. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol. Rev. 144, 225-244 (1995).